Avstera Therapeutics
PrivateLast Round
Accelerator
Oct 13, 2023
Total Funding Raised
$9.55M
Company Overview
Avstera Therapeutics operates in Healthcare & Life Sciences and is based in Malvern, Pennsylvania. Its latest recorded funding round was an Accelerator round in October 2023.
Avstera Therapeutics is a biotechnology company that develops therapies to address the significant needs of advanced cancer patients with limited or no treatment options.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avstera Therapeutics Comparables
Compare Avstera Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SIRPant Immunotherapeutics | 80% | |
| United Immunity, Co., Ltd. | 78% | |
| Jubilant Pharmova Limited | 78% |
For institutional investors. Book with your work email.
Avstera Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Oct 13, 2023 | ||||
| Series A | Oct 2, 2023 | ||||
| Seed | Nov 9, 2022 |
For institutional investors. Book with your work email.
Avstera Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Pennsylvania Office of Investments | Seed |
| Togo Ventures | Series A |
| Backswing Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors grew 110% MoM, reaching 1.7K.
- Jul 2, 2025
Monthly visitors increased 2623% from 30 to 817.
For institutional investors. Book with your work email.
Avstera Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Avstera Therapeutics's valuation, stock price, and market status.
Is Avstera Therapeutics a public or private company?
Avstera Therapeutics is a private company.
What is the current stock price of Avstera Therapeutics?
Avstera Therapeutics is a private company, so its shares have no public market price. Caplight tracks Avstera Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Avstera Therapeutics worth (valuation)?
Valuation information for Avstera Therapeutics is not publicly available.
Can I buy Avstera Therapeutics stock?
Avstera Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Avstera Therapeutics's last funding round?
Avstera Therapeutics's most recent funding round was Accelerator on October 13, 2023.
Who are the main investors in Avstera Therapeutics?
Key investors in Avstera Therapeutics include University of Pennsylvania Office of Investments, Togo Ventures, Backswing Ventures.
Will Avstera Therapeutics IPO soon?
No public IPO plans have been announced for Avstera Therapeutics.
How can I track Avstera Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Avstera Therapeutics's shares on secondary markets.